MedTrace Logo

Dexamethasone Infusion in Community-acquired Pneumonia

NCT00471640 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2010-09-27

No results posted yet for this study

Summary

The purpose of this study is to determine whether dexamethasone reduces the length of hospital stay in patient with a community-acquired pneumonia.

Conditions

Interventions

DRUG

dexamethasone

4 days 5 mg

Sponsors & Collaborators

  • St. Antonius Hospital

    lead OTHER

Principal Investigators

  • D Biesma, dr. · St. Antonius Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00471640 on ClinicalTrials.gov